InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,070.55
(
1.20%
)
US TECH 100
17,100.00
(
2.07%
)
Dow Jones
38,503.69
(
0.69%
)
Brent Oil
87.62
(
0.06%
)
Bitcoin
66,600.00
(
0.29%
)
Post# of 251572
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119459
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 240151

Wednesday, 05/18/2022 12:14:50 PM

Wednesday, May 18, 2022 12:14:50 PM

Post# of 251572
FDA rejects fluvoxamine* for COVID treatment based on insufficient evidence of efficacy:

https://endpts.com/unpersuaded-by-the-data-fda-rejects-cheap-generic-ssri-as-a-covid-19-drug/

*f/k/a Luvox, formerly FDA-approved for treating OCD.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up